A new meta-analysis shows a strong association between low levels of preformed donor-specific HLA antibodies (DSAs) detected using sensitive solid-phase assays and an increased risk of renal allograft failure. These findings have important implications for stratifying patients with DSAs for organ allocation and for the use of alloantigen desensitization therapies.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Trials Open Access 11 January 2019
-
Fcγ Receptors in Solid Organ Transplantation
Current Transplantation Reports Open Access 03 October 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mohan, S. et al. Donor-specific antibodies adversely affect kidney allograft outcomes. J. Am. Soc. Nephrol. 12, 2061–2071 (2012).
Einecke, G. et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am. J. Transplant. 9, 2520–2531 (2009).
Gaston, R. S. et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 90, 68–74 (2010).
Sellares, J. et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am. J. Transplant. 12, 388–399 (2012).
Colvin, R. B. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J. Am. Soc. Nephrol. 18, 1046–1056 (2007).
Vo, A. A. et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N. Engl. J. Med. 359, 242–251 (2008).
Lefaucheur, C. et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J. Am. Soc. Nephrol. 21, 1398–1406 (2010).
Lefaucheur, C. et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 381, 313–319 (2013).
Lai, C. H. et al. Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy. Transplantation 92, 48–53 (2011).
Chin, C. et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J. Heart Lung Transplant. 30, 158–163 (2011).
Acknowledgements
We would like to acknowledge the support of the Paris Cardiovascular Research Centre University Paris, Descartes and the Transplant Immunotherapy Program and HLA Laboratory at Cedars-Sinai Medical Center.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Loupy, A., Jordan, S. Donor-specific HLA antibodies and renal allograft failure. Nat Rev Nephrol 9, 130–131 (2013). https://doi.org/10.1038/nrneph.2013.18
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2013.18
This article is cited by
-
Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
Trials (2019)
-
Rabbit anti-human thymocyte immunoglobulin for the rescue treatment of chronic antibody-mediated rejection after pediatric kidney transplantation
Pediatric Nephrology (2017)
-
Fcγ Receptors in Solid Organ Transplantation
Current Transplantation Reports (2016)
